Literature DB >> 22901264

Zebrafish xenografts as a tool for in vivo studies on human cancer.

Martina Konantz1, Tugce B Balci, Udo F Hartwig, Graham Dellaire, Maya C André, Jason N Berman, Claudia Lengerke.   

Abstract

The zebrafish has become a powerful vertebrate model for genetic studies of embryonic development and organogenesis and increasingly for studies in cancer biology. Zebrafish facilitate the performance of reverse and forward genetic approaches, including mutagenesis and small molecule screens. Moreover, several studies report the feasibility of xenotransplanting human cells into zebrafish embryos and adult fish. This model provides a unique opportunity to monitor tumor-induced angiogenesis, invasiveness, and response to a range of treatments in vivo and in real time. Despite the high conservation of gene function between fish and humans, concern remains that potential differences in zebrafish tissue niches and/or missing microenvironmental cues could limit the relevance and translational utility of data obtained from zebrafish human cancer cell xenograft models. Here, we summarize current data on xenotransplantation of human cells into zebrafish, highlighting the advantages and limitations of this model in comparison to classical murine models of xenotransplantation.
© 2012 New York Academy of Sciences.

Entities:  

Mesh:

Year:  2012        PMID: 22901264     DOI: 10.1111/j.1749-6632.2012.06575.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  80 in total

Review 1.  Fishing forward and reverse: Advances in zebrafish phenomics.

Authors:  Ricardo Fuentes; Joaquín Letelier; Benjamin Tajer; Leonardo E Valdivia; Mary C Mullins
Journal:  Mech Dev       Date:  2018-08-18       Impact factor: 1.882

2.  Patient-derived xenograft in zebrafish embryos: a new platform for translational research in neuroendocrine tumors.

Authors:  Germano Gaudenzi; Manuela Albertelli; Alessandra Dicitore; Roberto Würth; Federico Gatto; Federica Barbieri; Franco Cotelli; Tullio Florio; Diego Ferone; Luca Persani; Giovanni Vitale
Journal:  Endocrine       Date:  2016-08-02       Impact factor: 3.633

3.  A protocol for genetic induction and visualization of benign and invasive tumors in cephalic complexes of Drosophila melanogaster.

Authors:  Ajay Srivastava
Journal:  J Vis Exp       Date:  2013-09-11       Impact factor: 1.355

Review 4.  The study of glioma by xenotransplantation in zebrafish early life stages.

Authors:  Miloš Vittori; Helena Motaln; Tamara Lah Turnšek
Journal:  J Histochem Cytochem       Date:  2015-06-24       Impact factor: 2.479

Review 5.  Zebrafish patient avatars in cancer biology and precision cancer therapy.

Authors:  Maurizio Fazio; Julien Ablain; Yan Chuan; David M Langenau; Leonard I Zon
Journal:  Nat Rev Cancer       Date:  2020-04-06       Impact factor: 60.716

6.  Invasive Behavior of Human Breast Cancer Cells in Embryonic Zebrafish.

Authors:  Jiang Ren; Sijia Liu; Chao Cui; Peter Ten Dijke
Journal:  J Vis Exp       Date:  2017-04-25       Impact factor: 1.355

7.  Mass spectrometry imaging in zebrafish larvae for assessing drug safety and metabolism.

Authors:  Mariana Asslan; Nidia Lauzon; Maja Beus; Dusica Maysinger; Simon Rousseau
Journal:  Anal Bioanal Chem       Date:  2021-06-26       Impact factor: 4.142

Review 8.  Zebrafish as a disease model for studying human hepatocellular carcinoma.

Authors:  Jeng-Wei Lu; Yi-Jung Ho; Yi-Ju Yang; Heng-An Liao; Shih-Ci Ciou; Liang-In Lin; Da-Liang Ou
Journal:  World J Gastroenterol       Date:  2015-11-14       Impact factor: 5.742

Review 9.  Zebrafish models of cardiovascular disease.

Authors:  Despina Bournele; Dimitris Beis
Journal:  Heart Fail Rev       Date:  2016-11       Impact factor: 4.214

10.  Ecotropic viral integration site 1, a novel oncogene in prostate cancer.

Authors:  A Queisser; S Hagedorn; H Wang; T Schaefer; M Konantz; S Alavi; M Deng; W Vogel; A von Mässenhausen; G Kristiansen; S Duensing; J Kirfel; C Lengerke; S Perner
Journal:  Oncogene       Date:  2016-09-12       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.